"This is a significant milestone for us as it demonstrates continued strong demand for SomnoDent® sleep apnea treatment," said Ralf Barschow, President & CEO of SomnoMed. "With more than 100,000 patients and counting we are continuing to grow and expand the products and services associated with SomnoDent sleep apnea treatment."
We look forward to announcing further details associated with this 100,000 treatment in June.
SomnoMed is a public company (SOM.AX) providing diagnostic and treatment solutions for Sleep Breathing Disorders such as Obstructive Sleep Apnea. SomnoMed was commercialized on the basis of extensive clinical research. Supporting independent clinical research, continuous innovation and instituting medical manufacturing standards has resulted in SomnoDent® becoming the state-of-the-art and clinically proven medical oral appliance therapy for obstructive sleep apnea. For additional information, visit SomnoMed at www.somnomed.com.
For advertising and promotion on HealthNewsDigest.com please contact Mike McCurdy: tvmike13@HealthNewsDigest.com or 877-634-9180
HealthNewsDigest.com is syndicated worldwide, to thousands of journalists and health-related websites. www.HealthNewsDigest.com
Top of Page
Us | Job Listings
| Help | Site
Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer